Abstract
Inflammatory biomarkers such as neutrophil-to-lymphocyte ratio (NLR) prognostic predictors in patients (pts) with breast cancer (BC). However, the relationship between NLR prognostic capacity and the different stages of early TNBC remains unexplored. We aim to assess the prognostic value of NLR in TNBC pts treated with neoadjuvant chemotherapy (NACT) according to clinical stages (CS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
